Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab

A 68‐year‐old male patient with squamous cell carcinoma (cT4N2M0) of the left upper lobe received chemoradiotherapy followed by durvalumab, an immune checkpoint inhibitor. The tumour responded well to the therapy, but an infiltrative shadow appeared in the left upper lobe, which was outside the radi...

Full description

Saved in:
Bibliographic Details
Published in:Respirol Case Rep
Main Authors: Taima, Kageaki, Tanaka, Hisashi, Itoga, Masamichi, Ishioka, Yoshiko, Kurose, Akira, Tasaka, Sadatomo
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Ltd 2020
Subjects:
Case Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7211830/
https://ncbi.nlm.nih.gov/pubmed/32399215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.580
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items